PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
3.66%
Net income growth under 50% of MRVL's 209.30%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
7.41%
Some D&A expansion while MRVL is negative at -1.26%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-20.09%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
14.97%
SBC growth well above MRVL's 1.11%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-3110.34%
Negative yoy working capital usage while MRVL is 93.80%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
241.67%
AR growth while MRVL is negative at -1.60%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
22.34%
Inventory growth well above MRVL's 30.75%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
-401.64%
Negative yoy AP while MRVL is 34.26%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-40.30%
Negative yoy usage while MRVL is 412.01%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-1800.00%
Both negative yoy, with MRVL at -95.95%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-69.13%
Negative yoy CFO while MRVL is 23.98%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-22.40%
Negative yoy CapEx while MRVL is 36.70%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
100.00%
Acquisition spending well above MRVL's 91.94%. Michael Burry would suspect heavier integration risk or short-term free cash flow drain vs. competitor.
39.96%
Purchases growth of 39.96% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
2.54%
Liquidation growth of 2.54% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
40.00%
We have some outflow growth while MRVL is negative at -4700.00%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
94.56%
Investing outflow well above MRVL's 60.05%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-4.19%
We cut yoy buybacks while MRVL is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.